Disc Medicine, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 26.95 million compared to USD 22.78 million a year ago. Basic loss per share from continuing operations was USD 1.09 compared to USD 1.2 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
31.28 USD | -2.80% | +0.39% | -46.10% |
May. 09 | Disc Medicine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 08 | Stifel Raises Price Target on Disc Medicine to $73 From $71, Keeps Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.10% | 796M | |
+39.41% | 50.93B | |
-0.22% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+12.79% | 26.02B | |
-22.39% | 18.9B | |
+8.94% | 13.21B | |
+24.56% | 12.17B | |
+29.10% | 12.16B |
- Stock Market
- Equities
- IRON Stock
- News Disc Medicine, Inc.
- Disc Medicine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024